| Tiotropium in combination with placebo, salmeterol, or fluticasone–salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial SD Aaron, KL Vandemheen, D Fergusson, F Maltais, J Bourbeau, ... Annals of internal medicine 146 (8), 545-555, 2007 | 993 | 2007 |
| Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial DR Anderson, SR Kahn, MA Rodger, MJ Kovacs, T Morris, A Hirsch, ... Jama 298 (23), 2743-2753, 2007 | 745 | 2007 |
| Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis SR Kahn, A Hirsch, I Shrier Archives of internal medicine 162 (10), 1144-1148, 2002 | 432 | 2002 |
| Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability C Kearon, K de Wit, S Parpia, S Schulman, M Afilalo, A Hirsch, ... New England Journal of Medicine 381 (22), 2125-2134, 2019 | 336 | 2019 |
| Functional and exercise limitations after a first episode of pulmonary embolism: results of the ELOPE prospective cohort study SR Kahn, AM Hirsch, A Akaberi, P Hernandez, DR Anderson, PS Wells, ... Chest 151 (5), 1058-1068, 2017 | 264 | 2017 |
| High prevalence of occult left heart disease in scleroderma-pulmonary hypertension BD Fox, A Shimony, D Langleben, A Hirsch, L Rudski, R Schlesinger, ... European Respiratory Journal 42 (4), 1083-1091, 2013 | 178 | 2013 |
| Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trial SR Kahn, I Shrier, S Shapiro, AH Houweling, AM Hirsch, RD Reid, ... Cmaj 183 (1), 37-44, 2011 | 158 | 2011 |
| Body mass index is associated with the development of the post-thrombotic syndrome W Ageno, E Piantanida, F Dentali, L Steidl, V Mera, A Squizzato, ... Thrombosis and haemostasis 89 (02), 305-309, 2003 | 156 | 2003 |
| Quality of life, dyspnea, and functional exercise capacity following a first episode of pulmonary embolism: results of the ELOPE cohort study SR Kahn, A Akaberi, JT Granton, DR Anderson, PS Wells, MA Rodger, ... The American journal of medicine 130 (8), 990. e9-990. e21, 2017 | 150 | 2017 |
| Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension D Langleben, BW Christman, RJ Barst, VC Dias, N Galič, ... American heart journal 143 (5), 4A-10A, 2002 | 100 | 2002 |
| Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline S Mehta, D Helmersen, S Provencher, N Hirani, FD Rubens, M De Perrot, ... Canadian respiratory journal 17 (6), 301-334, 2010 | 98 | 2010 |
| Effect of chronic infusion of epoprostenol on echocardiographic right ventricular myocardial performance index and its relation to clinical outcome in patients with primary … I Sebbag, LG Rudski, J Therrien, A Hirsch, D Langleben American Journal of Cardiology 88 (9), 1060-1063, 2001 | 87 | 2001 |
| Sustained symptomatic, functional, and hemodynamic benefit with the selective endothelin-A receptor antagonist, sitaxsentan, in patients with pulmonary arterial hypertension: a … D Langleben, AM Hirsch, E Shalit, L Lesenko, RJ Barst Chest 126 (4), 1377-1381, 2004 | 77 | 2004 |
| Etiology-specific endothelin-1 clearance in human precapillary pulmonary hypertension D Langleben, J Dupuis, I Langleben, AM Hirsch, M Baron, JL Senécal, ... Chest 129 (3), 689-695, 2006 | 74 | 2006 |
| Long-term outcomes after pulmonary embolism: current knowledge and future research SR Kahn, AH Houweling, J Granton, L Rudski, C Dennie, A Hirsch Blood Coagulation & Fibrinolysis 25 (5), 407-415, 2014 | 60 | 2014 |
| NT-pro-BNP levels in patients with acute pulmonary embolism are correlated to right but not left ventricular volume and function SM Pasha, FA Klok, N van der Bijl, A de Roos, LJM Kroft, MV Huisman Thrombosis and haemostasis 108 (08), 367-372, 2012 | 54 | 2012 |
| Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial … D Langleben, SE Orfanos, M Giovinazzo, A Hirsch, M Baron, JL Senécal, ... Arthritis & Rheumatism 58 (4), 1156-1164, 2008 | 54 | 2008 |
| Risk for recurrent venous thromboembolism in patients with subsegmental pulmonary embolism managed without anticoagulation: a multicenter prospective cohort study G Le Gal, MJ Kovacs, L Bertoletti, F Couturaud, C Dennie, AM Hirsch, ... Annals of Internal Medicine 175 (1), 29-35, 2022 | 53 | 2022 |
| Unilateral pulmonary artery thrombotic occlusion: is distal arteriopathy a consequence? AM Hirsch, KM Moser, WR Auger, RN Channick, PF Fedullo American journal of respiratory and critical care medicine 154 (2), 491-496, 1996 | 53 | 1996 |
| High resolution computed tomography scoring systems for evaluating interstitial lung disease in systemic sclerosis patients D Assayag, S Kaduri, M Hudson, A Hirsch, M Baron Rheumatology 1 (10.4172), 1149-2161, 2012 | 52 | 2012 |
